Another study discovered that AIM2 suppressed CRC cell viability by inhibiting the PI3K/AKT pathway and caused an increase in the percentage of cells in G1 and G2/M phases, without affecting the S phase, ultimately promoting cell apoptosis38. This evidence concerns the gene AIM2 and colorectal carcinoma.